C. Niyibizi

发表

C. Niyibizi, M. Kim, Myung-Good Kim, 2000, Expert opinion on investigational drugs.

C. Niyibizi, Myung-Chul Kim, Myung‐chul Kim, 2000 .

GAG-augmented polysaccharide hydrogel: A novel biocompatible and biodegradable material to support chondrogenesisNo benefit of any kind will be received either directly or indirectly by the authors.

Freddie H. Fu, C. Evans, J. Suh, 2000 .

Intermittent sub-ambient interstitial hydrostatic pressure as a potential mechanical stimulator for chondrocyte metabolism.

C. Evans, J. Suh, G. Baek, 1999, Osteoarthritis and cartilage.

Effects of Culturing on the Stability of the Putative Murine Adipose Derived Stem Cells Markers.

C. Niyibizi, Feng Li, Jacquelyn R Maddox, 2009, The open stem cell journal.

A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen.

D. Eyre, C. Niyibizi, J. Wu, 1994, Biochemical and biophysical research communications.

Breast and Abdominal Adipose Multipotent Mesenchymal Stromal Cells and Stage-Specific Embryonic Antigen 4 Expression

C. Niyibizi, Feng Li, Jacquelyn R Maddox, 2012, Cells Tissues Organs.

Downregulation of human type III collagen gene expression by antisense oligodeoxynucleotide.

S. Woo, T. Shimomura, C. Niyibizi, 2005, Tissue engineering.

Medial collateral knee ligament healing. Combined medial collateral and anterior cruciate ligament injuries studied in rabbits.

S. Woo, J. Matyas, R. J. Fox, 1997, Acta orthopaedica Scandinavica.

The effects of age on rabbit MCL fibroblast matrix synthesis in response to TGF-β 1 or EGF

S. Woo, M. Deie, C. Allen, 1997, Mechanisms of Ageing and Development.

Antisense Oligonucleotides Reduce Synthesis of Procollagen α1 (V) Chain in Human Patellar Tendon Fibroblasts: Potential Application in Healing Ligaments and Tendons

S. Woo, T. Shimomura, C. Niyibizi, 2003, Connective tissue research.

Engraftability of Murine Bone Marrow-Derived Multipotent Mesenchymal Stem Cell Subpopulations in the Tissues of Developing Mice following Systemic Transplantation

C. Niyibizi, Feng Li, 2015, Cells Tissues Organs.

Pigment Epithelium Derived Factor Suppresses Expression of Sost/Sclerostin by Osteocytes: Implication for Its Role in Bone Matrix Mineralization

J. Tombran-Tink, C. Niyibizi, Feng Li, 2015, Journal of cellular physiology.

AAV Based Ex Vivo Gene Therapy in Rabbit Adipose-derived Mesenchymal Stem/Progenitor Cells for Osteogenesis

Freddie H. Fu, B. Wang, J. Huard, 2009 .

Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for paracrine activities in bone regeneration.

C. Niyibizi, Feng Li, Noel Whyte, 2012, Biochemical and biophysical research communications.

Distribution of murine adipose-derived mesenchymal stem cells in vivo following transplantation in developing mice.

C. Niyibizi, Feng Li, X. Liao, 2008, Stem cells and development.

The effects of recombinant human bone morphogenetic protein-2, recombinant human bone morphogenetic protein-12, and adenoviral bone morphogenetic protein-12 on matrix synthesis in human annulus fibrosis and nucleus pulposus cells.

James D. Kang, L. Gilbertson, P. Teng, 2008, The spine journal : official journal of the North American Spine Society.

Potential role for gene therapy in the enhancement of fracture healing.

P. Robbins, C. Evans, C. Lattermann, 1998, Clinical orthopaedics and related research.

Distribution of Single‐Cell Expanded Marrow Derived Progenitors in a Developing Mouse Model of Osteogenesis Imperfecta Following Systemic Transplantation

C. Niyibizi, Feng Li, Xujun Wang, 2007, Stem cells.

Pigment epithelium derived factor regulates human Sost/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk/GSK-3beta/beta-catenin signaling.

J. Tombran-Tink, C. Niyibizi, Feng Li, 2018, Biochimica et biophysica acta. Molecular basis of disease.

Transfer of lacZ marker gene to the meniscus.

Freddie H. Fu, P. Robbins, C. Evans, 1999, The Journal of bone and joint surgery. American volume.

Gene therapy for meniscal injury: enhanced synthesis of proteoglycan and collagen by meniscal cells transduced with a TGFbeta(1)gene.

Freddie H. Fu, P. Robbins, C. Evans, 2000, Osteoarthritis and cartilage.

Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo

J. Tombran-Tink, C. Niyibizi, Feng Li, 2019, Journal of Bone and Mineral Metabolism.

Pigment epithelium derived factor upregulates expression of vascular endothelial growth factor by human mesenchymal stem cells: Possible role in PEDF regulated matrix mineralization.

J. Tombran-Tink, C. Niyibizi, Feng Li, 2016, Biochemical and biophysical research communications.

Pigment Epithelium‐Derived Factor Enhances Differentiation and Mineral Deposition of Human Mesenchymal Stem Cells

J. Tombran-Tink, C. Niyibizi, Feng Li, 2013, Stem cells.

Identification of the cartilage α 1(XI) chain in type V collagen from bovine bone

D. Eyre, C. Niyibizi, 1989 .

Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta.

C. Niyibizi, Feng Li, Xujun Wang, 2010, Bone.

In Vivo Expression of Human Growth Hormone by Genetically Modified Murine Bone Marrow Stromal Cells and its Effect on the Cells in Vitro

P. Robbins, C. Niyibizi, K. Suzuki, 2000, Cell transplantation.

Human placenta type V collagens. Evidence for the existence of an alpha 1(V) alpha 2(V) alpha 3(V) collagen molecule.

M. E. van der Rest, C. Niyibizi, P. Fietzek, 1984, The Journal of biological chemistry.

Potential of gene therapy for treating osteogenesis imperfecta.

C. Evans, C. Niyibizi, P. Robbins, 2000, Clinical orthopaedics and related research.

Gene therapy approaches for osteogenesis imperfecta

C. Niyibizi, P. Robbins, Z. Mi, 2004, Gene Therapy.

The Potential of Gene Therapy for Osteogenesis Imperfecta

J. Greenberger, C. Niyibizi, Patrick N. Smith, 2000 .

Transfer of proα2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of α1(I) and α2(I) heterotrimers in vitro and in vivo

P. Robbins, C. Niyibizi, Z. Mi, 2001 .

Ex Vivo Gene Therapy to Produce Bone Using Different Cell Types

J. Lee, D. Pelinkovic, J. Huard, 2000, Clinical orthopaedics and related research.

Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1.

P. Robbins, C. Evans, B. Johnstone, 2000, Arthritis and rheumatism.

Feasibility of Percutaneous Gene Transfer to an Atrophic Nonunion in a Rabbit

P. Robbins, C. Evans, C. Lattermann, 2004, Clinical orthopaedics and related research.

Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging

M Oyama, P. Robbins, C. Evans, 1999, Gene Therapy.

Multipotent mesenchymal stem cells from human subacromial bursa: potential for cell based tendon tissue engineering.

H. Ouyang, Christopher Niyibizi, C. Niyibizi, 2014, Tissue engineering. Part A.

Structural characteristics of cross-linking sites in type V collagen of bone. Chain specificities and heterotypic links to type I collagen.

D. Eyre, C. Niyibizi, 1994, European journal of biochemistry.

GAG-augmented polysaccharide hydrogel: a novel biocompatible and biodegradable material to support chondrogenesis.

Freddie H. Fu, F H Fu, C. Evans, 2000, Journal of biomedical materials research.

Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects.

Freddie H Fu, Freddie H. Fu, Johnny Huard, 2002, The Journal of rheumatology.

Cells derived from murine induced pluripotent stem cells (iPSC) by treatment with members of TGF-beta family give rise to osteoblasts differentiation and form bone in vivo

C. Niyibizi, Feng Li, 2012, BMC Cell Biology.

Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage

S. Bronson, C. Niyibizi, Feng Li, 2009, Journal of cellular biochemistry.

Potential implications of cell therapy for osteogenesis imperfecta.

C. Niyibizi, Feng Li, 2009, International journal of clinical rheumatology.

Identification and immunolocalization of type X collagen at the ligament-bone interface.

G. Gibson, C. Niyibizi, K. Kavalkovich, 1996, Biochemical and biophysical research communications.

Progenitors Systemically Transplanted into Neonatal Mice Localize to Areas of Active Bone Formation In Vivo: Implications of Cell Therapy for Skeletal Diseases

C. Niyibizi, Feng Li, Xujun Wang, 2006, Stem cells.

Cytokine‐induced tendinitis: A preliminary study in rabbits

S. Woo, G. Carlin, C. Niyibizi, 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Increased matrix synthesis following adenoviral transfer of a transforming growth factor β1 gene into articular chondrocytes

P. Robbins, C. Evans, B. Johnstone, 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Effect of growth factors on matrix synthesis by ligament fibroblasts

S. Woo, H. Georgescu, C. Niyibizi, 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Gene transfer to the tendon-bone insertion site

Freddie H. Fu, P. Robbins, C. Evans, 2004, Knee Surgery, Sports Traumatology, Arthroscopy.

Structural analysis of the extension peptides on matrix forms of type V collagen in fetal calf bone and skin.

D. Eyre, C. Niyibizi, 1993, Biochimica et biophysica acta.

The carboxypropeptide trimer of type II collagen is a prominent component of immature cartilages and intervertebral-disc tissue.

D. Eyre, C. Niyibizi, J. Wu, 1987, Biochimica et biophysica acta.

THE EFFECTS OF GROWTH FACTORS ON PROLIFERATION AND MATRIX SYNTHESIS OF FIBROBLASTS FROM GOAT MEDIAL COLLATERAL LIGAMENT

S. Woo, J. Wang, S. Takai, 2000 .

Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target.

P. Hebda, C. Evans, H. Georgescu, 1997, The Biochemical journal.

Incorporation of type I collagen molecules that contain a mutant alpha 2(I) chain (Gly580-->Asp) into bone matrix in a lethal case of osteogenesis imperfecta.

P. Byers, D. Eyre, J. Bonadio, 1992, The Journal of biological chemistry.

Collagens in an adult bovine medial collateral ligament: immunofluorescence localization by confocal microscopy reveals that type XIV collagen predominates at the ligament-bone junction.

S. Woo, C. Niyibizi, K. Kavalkovich, 1995, Matrix biology : journal of the International Society for Matrix Biology.

Low oxygen tension during incubation periods of chondrocyte expansion is sufficient to enhance postexpansion chondrogenesis.

A. Caplan, J. Dennis, C. Niyibizi, 2010, Tissue engineering. Part A.

The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells.

P. Robbins, C. Niyibizi, Z. Mi, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Biochemical analysis of collagens at the ligament-bone interface reveals presence of cartilage-specific collagens.

C. Niyibizi, C Niyibizi, K Kavalkovich, 1996, Archives of biochemistry and biophysics.

Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim).

J. Greenberger, C. Evans, M. Epperly, 1997, Bone.

Bone type V collagen: chain composition and location of a trypsin cleavage site.

D. Eyre, C. Niyibizi, 1989, Connective tissue research.

Adenoviral-mediated transfer of TGF-beta1 but not IGF-1 induces chondrogenic differentiation of human mesenchymal stem cells in pellet cultures.

Freddie H Fu, Freddie H. Fu, Paul D Robbins, 2005, Experimental hematology.

[TGF-beta-1 gene transfer in joint cartilage cells. Stimulating effect in extracellular matrix synthesis].

Freddie H. Fu, P. Robbins, C. Evans, 2000, Der Orthopade.

Type V collagen is increased during rabbit medial collateral ligament healing

Savio L-Y. Woo, S. Woo, Christopher Niyibizi, 2000, Knee Surgery, Sports Traumatology, Arthroscopy.

The use of growth factors, gene therapy and tissue engineering to improve meniscal healing

Freddie H. Fu, J. Huard, C. Niyibizi, 2000 .

Medial collateral ligament healing one year after a concurrent medial collateral ligament and anterior cruciate ligament injury: An interdisciplinary study in rabbits

S. Woo, C. Niyibizi, K. Kavalkovich, 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Identification of types II, IX and X collagens at the insertion site of the bovine achilles tendon.

M Oyama, C. Niyibizi, F. Fu, 1998, Matrix biology : journal of the International Society for Matrix Biology.

Cartilage tissue engineering for laryngotracheal reconstruction: comparison of chondrocytes from three anatomic locations in the rabbit.

J. Mansour, J. Welter, A. Caplan, 2007, Tissue engineering.

Interaction of TGF-beta1 and rhBMP-2 on human bone marrow stromal cells cultured in collagen gel matrix.

C. Niyibizi, M. Kim, 2001, Yonsei medical journal.

Cells derived from murine induced pluripotent stem cells (iPSC) by treatment with members of TGF-beta family give rise to osteoblasts differentiation and form bone in vivo

C. Niyibizi, Feng Li, 2012, BMC Cell Biology.

Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo.

C. Niyibizi, P. Robbins, Z. Mi, 2001, Journal of cellular biochemistry.

Pigment Epithelium Derived Factor Suppresses Expression of Sost/Sclerostin by Osteocytes: Implication for Its Role in Bone Matrix Mineralization

J. Tombran-Tink, C. Niyibizi, Feng Li, 2015, Journal of cellular physiology.